Skip to menu Skip to content Skip to footer
Professor Dan Siskind
Professor

Dan Siskind

Email: 
Phone: 
+61 7 3176 2860

Overview

Background

Prof Siskind trained as a psychiatrist in Australia and the United States. He graduated from medicine at the University of Queensland in 1998. After working with Doctors Without Borders in Chechnya in 2000, he became interested in psychiatry. He moved to Boston in 2002, where he did his psychiatry residency at Boston University and a Master of Public Health at Harvard University. He returned to Brisbane in June 2008 as a clinical academic psychiatrist at the Metro South Addiction and Mental Health Service. He completed his Ph.D in Feb 2014. His research interests include clozapine and treatment refractory schizophrenia, the physical health of people with severe and persistent mental illness, supported accommodation, assertive community treatment and mental health services research. He has been awarded an NHMRC Investigator Grant as an Emerging Leadership Fellow (2021-2025) and held an NHMRC Early Career Fellowship (2016-2019). He has a current CIA MRFF RCRDUN grant looking at treatments to reduce cardiometabolic morbidity among people with schizophrenia. He has over 200 peer reviewed publications, including first author in the highly ranked Lancet, World Psychiatry, Lancet Psychiatry, BJPsych, ANZJP, & Schizophrenia Bulletin. He is a named investigator on over $40 million in competitive research grants, with over $6 million as CIA.

Availability

Professor Dan Siskind is:
Available for supervision
Media expert

Fields of research

Research interests

  • Schizophrenia

  • Physical Health Comorbidity

Works

Search Professor Dan Siskind’s works on UQ eSpace

376 works between 2007 and 2025

281 - 300 of 376 works

2017

Journal Article

Mania associated with self-prescribed acetyl-L-carnitine in a man with bipolar I disorder

Goodison, Geraldine, Overeem, Kathie, de Monte, Veronica and Siskind, Dan (2017). Mania associated with self-prescribed acetyl-L-carnitine in a man with bipolar I disorder. Australasian Psychiatry, 25 (1), 13-14. doi: 10.1177/1039856216658831

Mania associated with self-prescribed acetyl-L-carnitine in a man with bipolar I disorder

2017

Journal Article

Motivational aftercare planning to better care: applying the principles of advanced directives and motivational interviewing to discharge planning for people with mental illness

Kisely, Steve, Wyder, Marianne, Dietrich, Josie, Robinson, Gail, Siskind, Dan and Crompton, David (2017). Motivational aftercare planning to better care: applying the principles of advanced directives and motivational interviewing to discharge planning for people with mental illness. International Journal of Mental Health Nursing, 26 (1), 41-48. doi: 10.1111/inm.12261

Motivational aftercare planning to better care: applying the principles of advanced directives and motivational interviewing to discharge planning for people with mental illness

2017

Conference Publication

Collaborations with Junior Colleagues for Building Research Capacity in the Public Sector

Siskind, D., Kisely, S. and Parker, S. (2017). Collaborations with Junior Colleagues for Building Research Capacity in the Public Sector. LONDON: SAGE PUBLICATIONS LTD. doi: 10.1177/0004867417702054

Collaborations with Junior Colleagues for Building Research Capacity in the Public Sector

2017

Conference Publication

Biopsychosocial and more: treating difficult to treat psychotic disorder

Siskind, D., Dark, F., Korman, N., Parker, S. and Clark, S. (2017). Biopsychosocial and more: treating difficult to treat psychotic disorder. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Biopsychosocial and more: treating difficult to treat psychotic disorder

2017

Conference Publication

Dopamine-Dysregulation Syndrome: a Systematic Review of Adiction to Dopamine and its Neuropsychiatric Consequences

Warren, N., Nyguen, D., O'Gorman, C., Lehn, A. and Siskind, D. (2017). Dopamine-Dysregulation Syndrome: a Systematic Review of Adiction to Dopamine and its Neuropsychiatric Consequences. RANZCP 2017 Congress, Adelaide, Australia, 30 April – 4 May 2017. LONDON: Sage.

Dopamine-Dysregulation Syndrome: a Systematic Review of Adiction to Dopamine and its Neuropsychiatric Consequences

2017

Journal Article

The prevalence of depression and anxiety disorders in indigenous people of the Americas: a systematic review and meta-analysis

Kisely, Steve, Alichniewicz, Karolina Katarzyna, Black, Emma B., Siskind, Dan, Spurling, Geoffrey and Toombs, Maree (2017). The prevalence of depression and anxiety disorders in indigenous people of the Americas: a systematic review and meta-analysis. Journal of Psychiatric Research, 84, 137-152. doi: 10.1016/j.jpsychires.2016.09.032

The prevalence of depression and anxiety disorders in indigenous people of the Americas: a systematic review and meta-analysis

2017

Conference Publication

Rehabilitation for Australians living with complex psychoses: epidemiological data on how the current gap between evidence and implementation may be bridged

Harvey, C., Farhall, J., Parsons, S., Lewis, J., Brophy, L., Moeller-Saxone, K., Grigg, M. and Siskind, D. (2017). Rehabilitation for Australians living with complex psychoses: epidemiological data on how the current gap between evidence and implementation may be bridged. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Rehabilitation for Australians living with complex psychoses: epidemiological data on how the current gap between evidence and implementation may be bridged

2017

Conference Publication

Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia

Siskind, D. (2017). Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia

2017

Conference Publication

How to disseminate your research findings?

Siskind, D. (2017). How to disseminate your research findings?. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

How to disseminate your research findings?

2017

Conference Publication

Schizophrenia and physical health - a whole body experience

Hahn, L., Kisely, S., Suetani, S., Lappin, Julia and Siskind, D. (2017). Schizophrenia and physical health - a whole body experience. LONDON: SAGE PUBLICATIONS LTD. doi: 10.1177/0004867417702054

Schizophrenia and physical health - a whole body experience

2017

Conference Publication

Are collaborations the key to successful public sector research?

Galletly, C., Sujeeve, S., Liu, D., Schubert, O. and Siskind, D. (2017). Are collaborations the key to successful public sector research?. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Are collaborations the key to successful public sector research?

2017

Conference Publication

Clozapine and ECT for treatment-refractory schizophrenia

Siskind, D. (2017). Clozapine and ECT for treatment-refractory schizophrenia. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Clozapine and ECT for treatment-refractory schizophrenia

2017

Conference Publication

Evaluating Effects of a Physical Activity Intervention Implemented At a Residential Mental Health Rehabilitation Unit

Korman, N., Siskind, D., Shah, S., Dark, F., Kendall, K. and Nadareishvili, K. (2017). Evaluating Effects of a Physical Activity Intervention Implemented At a Residential Mental Health Rehabilitation Unit. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Evaluating Effects of a Physical Activity Intervention Implemented At a Residential Mental Health Rehabilitation Unit

2017

Conference Publication

Integrating psychiatric rehabilitation into clinical practice

Killaspy, H., Harvey, C., Dark, F. and Siskind, D. (2017). Integrating psychiatric rehabilitation into clinical practice. RANZCP 2017 Congress, Adelaide, Australia, 30 April - 4 May 2017. London, United Kingdom: Sage Publications.

Integrating psychiatric rehabilitation into clinical practice

2016

Journal Article

Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?

Cherry, Scott, Siskind, Dan, Spivak, Valeria, Wysoczanski, Daniel and Halangoda, Priyangika (2016). Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?. Australasian Psychiatry, 24 (6), 602-603. doi: 10.1177/1039856216649768

Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?

2016

Journal Article

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

Siskind, Dan, McCartney, Lara, Goldschlager, Romi and Kisely, Steve (2016). Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry, 209 (5), 385-392. doi: 10.1192/bjp.bp.115.177261

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

2016

Journal Article

An evidence-based scale for the antecedents of depressive symptoms in Australian adults

Liu, Xin, Furuya-Kanamori, Luis, Siskind, Dan, Crompton, David, Williams, Gail M., Kostner, Karam, Vitetta, Luis and Doi, Suhail A. (2016). An evidence-based scale for the antecedents of depressive symptoms in Australian adults. Australasian Psychiatry, 24 (5), 466-469. doi: 10.1177/1039856216629842

An evidence-based scale for the antecedents of depressive symptoms in Australian adults

2016

Journal Article

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

Rossell, Susan L., Francis, Paul S., Galletly, Cherrie, Harris, Anthony, Siskind, Dan, Berk, Michael, Bozaoglu, Kiymet, Dark, Frances, Dean, Olivia, Liu, Dennis, Meyer, Denny, Neill, Erica, Phillipou, Andrea, Sarris, Jerome and Castle, David J. (2016). N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms. BMC Psychiatry, 16 (1) 320, 320. doi: 10.1186/s12888-016-1030-3

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

2016

Journal Article

Metabolic monitoring and management among clozapine users

Tso, Grace, Kumar, Puja, Jayasooriya, Thilini, Kisely, Steve and Siskind, Dan (2016). Metabolic monitoring and management among clozapine users. Australasian Psychiatry, 25 (1), 48-52. doi: 10.1177/1039856216665282

Metabolic monitoring and management among clozapine users

2016

Journal Article

Successful rechallenge with clozapine after treatment associated eosinophilia

McArdle, Peter A., Siskind, Dan J., Kolur, Uday, Parker, Stephen, Korman, Nicole and Purushothaman, Subramanian (2016). Successful rechallenge with clozapine after treatment associated eosinophilia. Australasian Psychiatry, 24 (4), 365-367. doi: 10.1177/1039856216654399

Successful rechallenge with clozapine after treatment associated eosinophilia

Funding

Current funding

  • 2024 - 2028
    A hybrid-II implementation-effectiveness trial of a peer-supported self-management tool for young people in preparation for early intervention in psychosis service discharge (MY PREP-ED) (Ex USYD)
    Medical Research Futures Fund
    Open grant
  • 2023 - 2028
    Self-care of Multimorbidity in schizophrenia supported by Peer workers: a Co-designed health Information Technology (SiMPlicITy) (externally led NHMRC 2022 Targeted Call administered via Uni of Syd)
    University of Sydney
    Open grant
  • 2023 - 2027
    Using risk profiles to overcome challenges in incorporating polygenic risk scores into clinical mental health practice (QIMR administered MRFF Genomics Health Future Mission grant)
    Queensland Institute of Medical Research
    Open grant
  • 2022 - 2029
    Schizophrenia and Weight Improvement From Tirzepatide (SWIFT)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2027
    Mental Health Australia General Clinical Trial Network (MAGNET) (MRFF Million Minds Mental Health Research Grant Led by Deakin University)
    Deakin University
    Open grant
  • 2021 - 2025
    Reducing the mortality gap for people with schizophrenia
    NHMRC Investigator Grants
    Open grant
  • 2020 - 2026
    Helping people with schizophrenia living longer, healthier lives
    Queensland Advancing Clinical Research Fellowship
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant

Past funding

  • 2023 - 2024
    Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz)
    University of Sydney
    Open grant
  • 2022 - 2024
    A 40-year life course study of the effects of child maltreatment using linked birth cohort and administrative health data
    Metro South Health Research Support Scheme Project Grant
    Open grant
  • 2019 - 2021
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies
    NHMRC Project Grant
    Open grant
  • 2019 - 2022
    Identifying and treating patients with psychosis who are positive to anti-neuronal antibodies (NHMRC Project Grant led by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2018 - 2020
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    Society for Mental Health Research Inc
    Open grant
  • 2018 - 2019
    The efficacy of adjunctive metformin to attenuate weight gain and visceral adiposity, and prevent conversion to diabetes in people with schizophrenia newly commenced on clozapine
    The Australian Diabetes Society
    Open grant
  • 2017 - 2018
    Avant Doctors in Training Research Scholarship Program 2017
    Avant Mutual Group Limited
    Open grant
  • 2017 - 2019
    A comparison study of three physical activity measurement tools examining acceptability in people with psychotic disorders
    Society for Mental Health Research Inc
    Open grant
  • 2017 - 2019
    Acceptability of physical activity measures in people with psychotic disorders
    Royal Australian & New Zealand College Psychiatrists
    Open grant
  • 2016 - 2019
    Cardiometabolic Health of People with Severe and Persistent Mental Illness
    NHMRC Early Career Fellowships
    Open grant
  • 2016 - 2019
    N-Acetyl Cysteine In Schizophrenia Resistant to Clozapine: A Double-Blind Randomised Placebo-Controlled Trial Targeting Negative Symptoms (NHMRC Project grant administed by Uni Melbourne)
    University of Melbourne
    Open grant
  • 2015 - 2017
    Vaporising smoking-related harms in people with severe and persistent mental illness: A study of the acceptability of vaporised nicotine products for smoking cessation or long-term substitution
    Monash University
    Open grant
  • 2015 - 2017
    Quantifying the burden of perinatal depression in Australia and New Zealand
    RANZCP Pat, Toni and Peter Kinsman Research Scholarship
    Open grant
  • 2013 - 2016
    A MAP to better care: Applying the principles of advanced directives and motivational interviewing to discharge planning for psychiatric patients
    Australian Centre for Health Services Innovation
    Open grant

Supervision

Availability

Professor Dan Siskind is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Professor Dan Siskind directly for media enquiries about:

  • Cardiometabolic co-morbidity of schizophrenia
  • Treatment Refractory Schizophrenia

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au